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ABSTRACT
The established protocol for DNase I footprinting
has been modified to allow multiple parallel reac-
tions to be rapidly performed in 96-well microtitre
plates. By scrutinizing every aspect of the tradi-
tional method and making appropriate modifica-
tions it has been possible to considerably reduce
the time, risk of sample loss and complexity of
footprinting, whilst dramatically increasing the yield
of data (30-fold). A semi-automated analysis system
has also been developed to present footprinting
data as an estimate of the binding affinity of each
tested compound to any base pair in the assessed
DNA sequence, giving an intuitive ‘one compound–
one line’ scheme. Here, we demonstrate the
screening capabilities of the 96-well assay and
the subsequent data analysis using a series of six
pyrrolobenzodiazepine-polypyrrole compounds and
human Topoisomerase II alpha promoter DNA. The
dramatic increase in throughput, quantified data
and decreased handling time allow, for the first
time, DNase I footprinting to be used as a screening
tool to assess DNA-binding agents.
INTRODUCTION
DNase I footprinting is a powerful in vitro technique used
to identify ligand–DNA interactions at speciﬁc DNA
sequences (1,2). For the past two decades it has been the
fundamental assay used to determine the sequence-
selectivity for both proteins and DNA-binding com-
pounds (3,4). Through manipulations of quantiﬁed data,
it has become possible to further utilize DNase I
footprinting to indirectly measure thermodynamic and
kinetic properties of interactions (5,6). Typically it is
possible, from one or two footprinting experiments, to
locate a ligand’s preferential binding sites on a desired
short (100–200bp) target DNA sequence, and
characterize the ligand by calculating the binding aﬃnities
at such sites (7).
Unfortunately, as many researchers will testify, DNase
I footprinting is a labour-intensive procedure which may
take several days to prepare and carry out (2,7,8).
Furthermore, it traditionally involves the undesirable
use of radioisotopes and requires tricky ethanol precipita-
tion steps. Modiﬁcations of the DNase I footprinting
protocol have been reported, and these have sought to
improve the assay through the removal of radioisotope
use and/or ethanol precipitation steps (9–13). However,
use of these modiﬁed assays has not become com-
monplace, possibly as all describe single-tube methods
that ultimately still require signiﬁcant labour in order to
yield data.
For many researchers, including us, the greatest desire
is to decrease the data turnover time of DNase I
footprinting to maximize productivity. In the current
age of drug discovery and ‘omics’, the need for medium/
high-throughput assays is evident, with the same tech-
nique performed repeatedly, in order to satisfy large
sample sets (14). This is achieved in most experiments by
carrying-out reactions in parallel, with the 96-well
microtitre plate as the industry standard. Working in
the ﬁeld of drug design and discovery, it was our own wish
to use DNase I footprinting as a screening tool, increasing
the throughput such that it could be used to assess
libraries of compounds produced by combinatorial
methods.
Therefore, through scrutiny of every aspect of the
standard protocol for DNase I footprinting, we developed
a rapid assay that utilizes the 96-well format and gives
increased throughput along with decreased risk, error and
processing times. In the process of developing the method,
it also became clear that an equally expedient analysis
procedure would be required to handle the large yield
of data. To this end, a semi-automated analysis protocol
was also designed, tying together gel quantiﬁcation
software with custom-designed programs to produce a
single ‘footprinting proﬁle’ for each ligand across several
hundred base pairs of sequence. The resultant protocol
*To whom correspondence should be addressed. Tel: þ44 (0)20 7679 9326; Fax: þ44 (0)20 7436 2956; Email: john.hartley@ucl.ac.uk
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.provides a quick and simple microtitre-based DNase I
footprinting assay that is suitable for use as a quantitative
screening-tool.
MATERIALS AND METHODS
DNA cloning andplasmid purification
The proximal 705bp of the human Topoisomerase II
alpha (TOPOIIa) promoter was ampliﬁed by PCR
from human genomic DNA (Promega) using primers
TIIA-F (CACCGCACACAGCCTAC) and TIIA-R
(TGGTGACGGTCGTGAAG) (Supplementary Figure
1). The resulting fragment was ligated into the pGEM-T
Easy plasmid vector using a commercial kit (Promega).
After transforming Escherichia coli XL-10 Gold strain
(Stratagene), plasmid containing the TOPOIIa fragment
was ampliﬁed and puriﬁed using a midiprep puriﬁcation
system kit (Qiagen). The generated template plasmid
was veriﬁed by DNA sequencing (UCL Services,
London, UK).
Preparation ofend-labelled DNA molecules
IR700 dye (LI-COR Biosciences) end-labelled DNA was
produced in 48 25ml reactions by standard Taq (Sigma)
PCR ampliﬁcation from the plasmid template. Labelled
and non-labelled PCR primers (Thermo) directed to the T7
and SP6 promoter sequences of pGEM-T Easy plasmid
were used, with the IR700 dye attached to the 50-end of the
T7 primer when producing forward-labelled target, and
attached to the 50-end of the SP6 primer when producing
reverse-labelled target. Products were puriﬁed by PCR
clean-up column with 12 reactions per column (Qiagen)
and ﬁnally eluted into a total of 300mlo f0 . 1m MT r i s - H C l
pH 8.5. The IR700 end-labelled DNA concentration of
both targets was estimated by measuring optical density
both at 260nm wavelength (for DNA) and at 685nm
wavelength (for IR700 dye). DNA product was then diluted
with 0.1mM Tris-HCl pH 8.5 to give a 100nM stock and
this was stored at  208C. In both cases, the DNA fragment
consisted of the 705bp TOPOIIa promoter region plus
177bp of ﬂanking pGEM-T Easy sequence.
Drug–DNA footprinting
In a V-bottom polypropylene 96-well plate (Eppendorf),
50ml drug–DNA reactions were prepared against the two
IR700 dye end-labelled DNA targets. In each case, six
test agents were incubated with each DNA target at eight
concentrations (one column) per drug: 0, 1.6, 8, 40, 200,
1000, 5000 and 25000nM. Serial drug dilutions were
prepared beforehand in 100% DMSO at 20  ﬁnal
concentration allowing 2.5ml to be added to each reaction
giving a ﬁnal mix of 5% DMSO, 50mM KCl, 20mM
Tris-HCl pH 7.5, 1mM MgCl2, 0.5mM DTT and 4nM
IR700 end-labelled DNA. Drug–DNA reactions were
incubated for 17h at room temperature before digestion
for 8min; initiated by adding 5ml of 50mM NaCl, 5mM
MgCl2 and 5mM MnCl2 containing 0.02 units of DNase
I (Promega). Digestion was stopped by adding 5mlo f
50mM EDTA and digested DNA samples were puriﬁed
with a 96-well vacuum ﬁltration system (Montage SEQ96,
Millipore), resuspending in 50ml 0.1mM Tris-HCl pH 8.5.
Samples were concentrated to dryness with a Speedvac
Evaporator (Thermo) and resuspended in 0.8ml forma-
mide containing 0.05% bromophenol blue.
Gel electrophoresis
Samples were denatured for 4min at 958C, and 48 samples
(the ﬁrst six columns) were loaded on a 52-lane sequencing
gel [41cm length, 0.25mm thick, containing 1  TBE, 7M
urea, 10% formamide, 5% Sequagel XR (National
Diagnostics, Hull, UK)]. A GA-speciﬁc chemical sequen-
cing ladder (15) produced in advance was co-loaded in two
lanes of the gel to act as markers. The gel was run for 5h
at 1500V, 35mA, 31.5W, 558C using a LI-COR model
4200 DNA Sequencer with e-Seq v2.0 Software (LI-COR
Biosciences). The remaining 48 samples (the reactions with
the reverse-labelled target) were subsequently loaded and
run on a second gel exactly as the ﬁrst 48 samples.
Footprinting gelimage analysis
Raw intensity proﬁles (pixel intensity with regard to pixel
position) for all 50 lanes were grouped in a CSV datasheet
following 1D gel analysis of each 16-bit TIFF image using
ImageQuant TL (GE Healthcare). With no background
subtraction, band detection was then carried out in
ImageQuant TL for the two marker lanes, ensuring that
bands matched all the G and A positions within the
analysed DNA sequence before exporting the lane
measurement tables to a CSV datasheet.
Creation of differential cleavage plots
The program, ‘footprint2’, was used to convert the gel
data into diﬀerential cleavage values. ‘footprint2’ is
written in Perl, and the Tk toolkit is used to provide
simple graphical input dialogs. The program input is CSV
MS Excel datasheets for the lane intensity proﬁles, the
band positions of one of the marker lanes (selected from
the two analysed) and the analysed DNA sequence.
The program proceeds in the following sequence:
(i) The raw intensity data (indexed by pixel) are sorted
into bins, so that every lane has the same number of
bins. This step corrects for variation in the lengths
of the lanes.
(ii) The marker lane and DNA sequence input are
analysed to convert the binned pixel data into data
indexed by sequence position.
(iii) The intensity data are smoothed by a running average
over a given number of base pairs, typically ﬁve.
(iv) Baseline correction. Each lane is separated into
segments (typically ten), and the minimum in each
segment found. These minima are ﬁtted to a
quadratic curve, and the curve used as the baseline
to subtract.
(v) Amplitude correction. Again each lane is separated
into segments (typically ten), and the range in each
segment found. These ranges are ﬁtted to a
quadratic curve, and the intensity at each point is
normalized by dividing by the ﬁtted range value.
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i is the normalized intensity of lane l at base
pair i, and I0
i is the normalied intensity of the
control ‘no drug’ lane at base pair i. For each drug,
the output data are used to plot individual graphs
of diﬀerential cleavage for all concentrations against
the target DNA sequence.
The quadratic ﬁtting was carried out using the Perl
Data Language (PDL) extension to Perl (16). All gel
bands were observed to have a systematic drift in baseline
signal and peak amplitude that was not adequately
corrected by a linear function. Polynomials of higher
order than quadratic were not found to improve
performance. Despite the multiple manipulations, running
the program takes only about 5s for each 50-lane gel.
Creation offootprint score graphs
Using a second Perl program, ‘hitsblock2’, the output ﬁle
from the ‘footprint2’ program was combined with manually
assigned diﬀerential cleavage cut-oﬀ values dc for each drug
to give a further output of a ‘score’ value assigned to each
base pair in the sequence for each of the six agents tested
per gel. The ‘score’ is deﬁned as log10cc, where cc is the
lowest concentration for each drug where the diﬀerential
cleavage at the base pair is below the dc value. For each
drug output data were used to plot individual graphs of
‘score’ against the target DNA sequence.
Further information on the software programs
described can be obtained from the corresponding author.
Standard
32P-radiolabelled DNaseI footprinting
As a comparison, compound 2 was footprinted against
32P-labelled TOPOIIa promoter DNA using a previously
described protocol (17) with minor modiﬁcations. A GA-
speciﬁc chemical sequencing ladder (15) was used and
drug was incubated with DNA at eight diﬀerent concen-
trations; 0, 1.6, 8, 40, 200, 1000, 5000 and 25000 nM.
RESULTS
To demonstrate the DNase I footprinting screen, a series
of DNA minor groove-binding compounds was assessed
using the TOPOIIa promoter region previously character-
ized (17,18). The investigated compounds (Figure 1) are
an established series of novel methyl ester-terminated
C8-linked pyrrolobenzodiazepine–poly(N-methylpyrrole)
conjugates (19). This PBD-polypyrrole series increases
in length from one to six consecutive pyrrole groups (1–6)
held together by peptide linkers. For the experiments
detailed here, a 705bp section of the proximal pro-
moter region of the TOPOIIa gene was investigated
(Supplementary Figure 1). The DNA target was ampliﬁed
by PCR to yield two footprinting fragments diﬀering
only by the strand on which they are 50-end labelled with
IR700 dye. The use of two fragments provided optimum
resolution of footprints along the investigated promoter
region.
DNaseI footprinting in 96-wellformat
A layout of six compounds assessed against two footprint-
ing fragments at eight diﬀerent concentrations was found
to give optimum use of the 96-well format and allowed all
liquid handling steps to be carried out using standard
multi-channel pipettes. Five-fold serial dilutions were
chosen, in order to give a suitable 5
6 ( 16000-fold)
range of reaction concentrations for each compound.
To circumvent any compound solubility issues, serial
dilutions were performed in 100% DMSO to give
20  concentration stocks in 96-well format that could
be prepared in advance (and stored long-term at  208C).
The presence of 5% DMSO in the ﬁnal reaction was tested
for its eﬀect on DNase I and found to be negligible
(data not shown).
In the development of the method, the clean up of
digestion products presented the only major hurdle to
carrying out multiple parallel DNase I footprinting
reactions in 96-well format. This step is typically achieved
through ethanol precipitation of the DNA, a procedure
that does not lend itself to microtitre plates. Thorough
testing of many technologies including magnetic beads,
dialysis and spin columns revealed the most eﬃcient and
usable DNA clean-up system to be a 96-well vacuum ﬁlter
plate originally designed to purify Sanger-sequencing
reaction products by membrane-based size-exclusion.
With digestion products safely retained on the plate
ﬁlter they can easily be washed, resuspended into low-salt
buﬀer, concentrated to dryness and resuspended into the
small volume of formamide (0.8ml) required for loading
on an automated sequencer.
InfraredDNase Ifootprinting
Previous research has described single-tube, non-
radioisotopic DNA-protein DNase I footprinting experi-
ments analysed on several automated sequencer systems
including an automated laser ﬂuorescent (ALF) sequencer
(10), capillary sequencers (12,13) and a LI-COR infrared
DNA sequencer (11). Of the three, the LI-COR system
had the highest sensitivity due to its use of infrared dyes
rather than traditional ﬂuorescent dyes (e.g. ﬂuorescein);
however, the capillary sequencers were the fastest and
easiest to use. Given that using low concentrations of
DNA is essential for quantitative footprinting experiments
(8), we chose to demonstrate our assay on the system with
the highest sensitivity—the LI-COR 4200 automated
























Figure 1. The investigated series of PBD-polyamide conjugate
compounds.
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sensitivity alternative to radioactive isotope labels such
as
32P and
33P (20) and the subsequent data collection on
an automated sequencer also allows for long read lengths
and as many as 64 samples per gel (21). For quantiﬁable
resolution, electrophoresis conditions were optimized,
both with the TOPOIIa DNA fragments described here
and with several other footprinting targets (data not
shown). Although the sequencer was fully capable of
resolving 4800nt in a single overnight run, it was found
that beyond approximately 500nt (5h), individual bands
could no longer be measured with a conﬁdence suitable for
the analysis. Additionally, it was found that standard
denaturing polyacrylamide gels had to be supplemented
with 10% formamide to increase further their denatura-
tion strength so as to prevent the formation of DNA
secondary structures (22).
The data from each run performed on the automated
sequencer are displayed as a 16-bit TIFF image, with two
high-resolution DNase I footprinting images produced per
96-well plate of reactions (Figure 2). Visual inspection
of these gel images reveals a considerably increased yield
of high quality footprinting data, unparalleled by con-
ventional radioactive DNase I footprinting.
To verify that infrared DNase I footprinting pro-
vides reliable data equivalent to standard footprinting
techniques, a 150bp section from Figure 2A is compared
to an equivalent
32P-radiolabelled DNase I footprinting
gel image in Supplementary Figure 2. Almost identical
digestion patterns are seen at equivalent concentrations,
despite the diﬀerences in label detection, reaction volumes
and electrophoretic resolution.
Quantitative analysis ofDNase I footprinting
Standard radioisope footprinting experiments are com-
monly subjected to quantitative analysis, in order to make
thermodynamic and kinetic measurements of ligand–
DNA interactions (6). A number of techniques have
been previously described for quantitative analysis that
interpret measurable changes in intensity of either a
footprinted ‘block’ of the gel image or in peak-ﬁtted
individual bands (23,24). Furthermore, several research
groups have made available software packages that carry
out such analyses (24,25). By virtue of both the vast
increase in quantiﬁable data per gel and the linear band
separation aﬀorded by the use of an automated sequencer,
none of the described analytical methods was fully suited
to the 96-well screening method described here. It was
therefore necessary for us to make our own reassessment
of footprint analysis, in order to establish a novel protocol
serving the needs of the assay.
The analysis of footprint data requires two steps:
(i) identifying footprints as regions of decreased band
intensity in lanes where compound has been introduced,
and (ii) locating the sites of these footprints by interpret-
ing the local DNA sequence using the GA-speciﬁc
chemical sequencing ladder. For our needs, we were
conﬁdent that image quantiﬁcation software packages
(e.g. IQTL, GE Healthcare) would be adequately able to
detect the necessary intensity changes; however, we were
required to develop a program to carry out the sequence
interpretation. To this eﬀect, a simple yet novel program
was designed to perform the interpretation of data from
image quantiﬁcation, using the band positions in the
GA-speciﬁc chemical sequencing ladder together with the
sequence of analysed DNA to assign nucleotide positions
to the intensity proﬁles of each sample lane.
With this section of the program in place, we then
sought to improve on existing techniques to normalize
sample data to take into account experimental inaccura-
cies due to pipetting error, variation in DNase I cleavage
eﬃciency and common ‘smiling’ and ‘warping’ eﬀects
of gel electrophoresis. Traditionally, this is achieved
by some form of background subtraction followed by
normalization of all band intensities to selected ‘invariant
band intensities’ (25). Selecting invariant bands/blocks
was regarded as particularly undesirable given the large
number of bands found on one of our infrared DNase I
footprinting gel images ( 25000); thus, a variation of this
was incorporated. First, when assigning nucleotide
Figure 2. Infrared gel electrophoresis images of DNase I footprinting
products following incubation of compounds 1–6 with TOPOIIa
promoter DNA. Compounds were incubated for 17h with TOPOIIa
promoter DNA IR-labelled on the sense (A) or antisense (B) strand.
Each gel consists of 50 lanes: two GA marker lanes (GA) and six sets
of eight lanes for compound (l–r; 0, 0.0016, 0.008, 0.04, 0.2, 1, 5 and
25mM). The sequence positions relating to Supplementary Figure 1 are
given vertically.
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variation in lane length due to gel electrophoresis eﬀects
was normalized. Also at this point, the slightly faster
migration of bands in the chemical sequencing ladder was
taken into account. Next, the nucleotide position-assigned
intensity proﬁles of each sample lane were normalized
for all other likely experimental inaccuracies via a series
of transformations that utilized automatically selected
invariants. Eﬀectively by treating proﬁles as waveforms,
normalization was achieved through polynomial transfor-
mations that modiﬁed the waveform amplitude, baseline
and tilt so that the proﬁle of each lane approximated that
of the nearest appropriate control (no ligand) lane at all
positions except those footprinted.
Following successful normalization and nucleotide
position assignment, we chose initially to express intensity
diﬀerences as logarithmic diﬀerential cleavage and present
these graphically (Figure 3B) as in previously reported
analyses (19,26,27). However, although such plots achieve
an attractive graphical representation of footprint sites, we
believed that they could be improved upon due to two
inherent disadvantages: (i) lines are required for every
concentration of each compound, making graphs cluttered
and making it awkward to compare multiple compounds,
and (ii) the experimenter is misled into interpreting the
magnitude of the diﬀerential cleavage as the strength
of interactions at the footprint—although in reality the
magnitude is a factor of the original intensity of the bands
in the no-compound control lane. To overcome these
features, we set out to write a program that could use
diﬀerential cleavage values to produce, for each com-
pound, a single ‘aﬃnity’ value for every DNA base. This
‘one compound–one line’ scheme intuitively reports the
strength of the footprint at any DNA site and facilitates
a rapid comparison of DNA-binding properties when
multiple compounds are assessed.
Our initial intention was to use quantitative DNase
I footprint titrations to determine an association constant
(Ka) for every single nucleotide by ﬁtting background-
corrected band intensities to the Hill equation (28).
Although this approach was successful at many binding
sites, its universal use was not feasible as band intensity
decreases were insuﬃcient in regions that were not
footprinted. Additionally, the requirement to model
thousands of curves required more computing power
and data manipulation than was practicable. Next, we
looked at a simpler approach that can be adopted when
the lowest concentrations at which footprints are observed
are greater than the concentration of DNA in the samples
(8). In this method, the ligand dissociation constant is
eﬀectively given by the ligand concentration required to
produce a 50% decrease in band intensity (29). In the
screen described here, observable decreases in band
intensity due to binding are almost always greater than
50% due to the 5-fold concentration diﬀerence between
sample lanes. Subsequently, it was possible to design a
simple program to determine, for every nucleotide
position, the ligand concentration at which a signiﬁcant
band intensity decrease is observed compared to the
control. This value, referred to as the ‘score’
(log concentration), gives a good approximation of the
dissociation constant by eﬀectively estimating the C50
value. The program uses the diﬀerential cleavage data and
a user-deﬁned diﬀerential cleavage cut-oﬀ value to
determine a ‘score’ for every nucleotide position by
reporting the lowest concentration at which the diﬀer-
ential cleavage value at that base is lower than the cut-oﬀ
value. The result is a ‘score’ proﬁle across the tested
concentration range that describes the apparent aﬃnity of
a compound to each position in the entire DNA sequence
tested. Positions with no band intensity decrease over the
tested range are assigned a ‘score’ equivalent to binding at
125mM, 5-fold above the maximum tested concentration;
which allows them to be easily disregarded. A plot of
the ‘score’ proﬁle allows primary binding sites to be
distinguished from secondary and tertiary binding sites,
as the primary sites are bound with a higher approxi-
mate association constant and thus receive a lower
‘score’ value (Figure 3C). In addition, the DNA-binding
properties of multiple compounds can readily be com-
pared when multiple ‘score’ proﬁles are displayed together
(Figure 4).
Figure 3. An example of the semi-automated analysis of DNase I
footprints. A short region of the gel image shown in Figure 2A is used
as an example to illustrate analysis of binding of compound 2 over
180bp. By converting the lane images (A) into intensity proﬁles, a
program-generated diﬀerential cleavage plot, (B) and a single ‘score’
proﬁle (C) for the compound can be rapidly produced (the cut-oﬀ value
is indicated by a broken line in the diﬀerential cleavage plot).
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A rapid 96-well DNase I footprinting screen was devel-
oped that gives readily comparable quantitative binding
data for multiple test agents over long sequences of DNA.
By increasing substantially the throughput of footprinting,
we have demonstrated the suitability of this assay as a
screening tool relevant in the current age of drug
discovery. A typical radioisotope DNase I footprinting
experiment might be able to assess up to a maximum of
two ligands over 100bp of DNA, whilst requiring
approximately 3–4 days to proceed from an unlabelled
DNA template to an analysable gel image (2,7,8). The
96-well format screen described herein permits the
assessment of 12 ligands over 500bp of DNA (or six
ligands over 1kb) in as little as two days, along with a
greatly decreased proportion of user-time spent on
diﬃcult liquid-handling steps, which could ultimately be
programmed to be carried-out by a benchtop robot
system. This represents up to a 30-fold increase in data
yield within a signiﬁcantly shortened timescale. Indeed,
within our lab, the screen is routinely used to assess 12
compounds over 500bp every 24h, using only one
automated sequencer. The described assay has the further
advantage of producing quantiﬁable, linearly-separated
band intensities collected in real-time and does not require
such unreliable steps as ethanol precipitation and the
transfer of an electrophoresis gel to blotting paper.
As with other previously described modiﬁcations to
DNase I footprinting (9–13), useful improvements are
aﬀorded by the introduction of an automated DNA
sequencing system and the omission of radioisotope
use—although in a well-equipped laboratory it would be
perfectly reasonable to use the 96-well procedure with
radiolabelled DNA. Despite the relative expense of
automated DNA sequencing systems, their versatility
allows them to be used for many other applications,
notably DNA sequencing (30), AFLP analysis, (31)
electrophoretic mobility shift assays (32) and in vivo
footprinting (33). Additionally, the dye labels utilized are
considerably safer, have long lifetimes and are low in cost
(34). It is also common to ﬁnd that such systems are
available for communal use in many research environ-
ments, and although ﬂuorescent sequencing systems are
more common than the LI-COR infrared system described
here, continual improvement in the ﬂuorescent dyes
and optics used by automated sequencing systems
should no longer prevent such ﬂuorophores being used
as an alternative to radioisotopes in exactly the same
method described here.
Ultimately, the optimization of the practical steps for
the DNase I footprinting screen were less challenging than
the development of the analysis procedure. As many
features of the screen were novel, no commercially
available programs were suitable for the entire analysis.
The ﬁnal analysis system is, in eﬀect, a hybrid between
existing image analysis software and our own programs,
and as such some degree of user-input is still required, in
order to transfer data between steps and to make
occasional informed judgements. Nevertheless, one advan-
tage of a semi-automated procedure over a fully auto-
mated procedure is that it allows the user to monitor the
analysis at several stages and in greater depth (25). With
the DNase I footprinting screen in particular, the use of a
semi-automated procedure allowed us to overcome the
diﬃculty of having a wide range of band intensities within
each lane (due to the inherent non-uniform cleavage of
DNA by DNase I). By allowing the user to monitor the
diﬀerential cleavage outputs, it became possible to ensure
that the desired ‘score’ data gave an accurate description
of the initial gel image data without compromising on
Figure 4. A comparison of footprint proﬁles of compounds 1–6 on the proximal region of the TOPOIIa promoter. Single footprint proﬁles were
program-generated starting with the IR footprint gel image shown in Figure 3A. Where no footprinting is seen, the sequence has been given an
arbitrary score of  3.9 (log 125mM). The DNA sequence is given in Supplementary Figure 1.
e89 Nucleic Acids Research, 2007, Vol. 35, No. 12 PAGE 6 OF8the speed of analysis. A further advantage of the
semi-automated procedure is that it introduces ﬂexibility
to the analysis. With only minor modiﬁcations, our
programs can be adjusted to analyse gel images of
diﬀerent dimensions (length, width, and number of
lanes) or even to analyse electrophoresis results from
alternative sequencing systems and from conventional
radioisotope footprinting. Indeed, the whole design of our
96-well DNase I footprinting screen is intentionally
modular, in order to permit the user to adapt the protocol
to suit their needs. For example, a researcher wanting to
screen a mutant library of transcription factors on several
promoters could perform the DNase I footprinting in
96-well format (incubating with proteinase K before
sample clean-up, in order to remove the protein content)
before resolving the gel images using standard radio-
isotope electrophoresis over several days. The subsequent
data could then be processed rapidly using the
semi-automated procedure providing the user with
readily-comparable proﬁles of how each mutation eﬀects
transcription factor binding.
The 30-fold increase in throughput aﬀorded by the
96-well DNase I footprinting assay allows, for the ﬁrst
time, the use of DNase I footprinting as a screening tool
for assessing the DNA-binding properties of ligands,
DNA-binding proteins and potentially therapeutic test
agents. In our lab, we have found it possible to work at a
capacity that allows as many as 42 compounds to be
characterized per week against a 500bp DNA target when
using the 5
6 concentration range described here. The
power of the assay is illustrated by the results described
here, obtained using the PBD-polypyrrole series. The full
series was characterized—including full analysis over
700bp of DNA and preparation of labelled DNA—in
a total time of just three days. By comparison, our
previous characterization that included analysis of the
series (over 200bp of DNA) took more than four weeks to
achieve (19). By comparing the ‘score’ proﬁles of a large
number of compounds, diﬀerences in binding-site size,
sequence-selectivity and aﬃnity can all be determined with
ease. In research programs to design novel drugs, these
data are invaluable for selecting lead compounds, direct-
ing further synthesis and in determining the nature of
drug–DNA interactions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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